If you liked this article you might like

Biotech Movers: Akebia, Editas, Novavax
Akebia Secures Exclusive Access to U.S. Dialysis Patients With Vifor-Fresenius Pact
Akebia Surges but is Still Undervalued, Making Takeover a Potential Remedy
Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka